Skip to content

Effect of Superficial Cervical Plexus Block on Post Operative Nausea and Vomiting in Tympanomastoid Operations

Effect of Superficial Cervical Plexus Block on Incidence and Severity of Post Operative Nausea and Vomiting in Tympanomastoid Operations in Adults, Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05504551
Enrollment
90
Registered
2022-08-17
Start date
2022-08-31
Completion date
2023-01-01
Last updated
2023-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea and Vomiting

Keywords

nause, vomiting, tympanomastoid operations

Brief summary

post operative nausea and vomiting are very common after tympanomastoid operations, in this study we are investigating the effect of superficial cervical plexus block on the incidence and severity of those post operative complications.

Detailed description

various treatments and regimens have been tried to overcome the problem of postoperative nausea and vomiting after tympanomastoid surgery. superficial cervical plexus block seems so promising in this regards as it may reduce the incidence and severity of PONV through 3 mechanisms: primarily through blocking vagal afferents to the middle ear which mediate the vomiting reflex, and secondarily through decreasing pain which aggravates PONV, and finally through decreasing intra and post operative opioid consumption due to adequate analgesia which in turn avoids opioids side effects including PONV. the study group will receive superficial cervical plexus block while the control will receive the same block while given placebo instead of (lidocain/bupivacaine mixture) incidence and severity of PONV will be recoded according to a scale to find the difference between both groups.

Interventions

SCP block is given using high frequency linear ultrasound probe connected to an ultrasound machine to visualize SCP posterior to the midpoint of SCM muscle. Once SCP is identified, a combination of 5 ml bupivacaine (0.5%) and 5 ml lidocaine (2%) are injected after negative aspiration followed by injection of 1 ml to confirm the area, using a 22 gauge B-bevel needle Echogenic Needle.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

study group receives superficial cervical plexus block with lidocaine and bupivacaine control group receives superficial cervical plexus block using normal saline as a placebo

Eligibility

Sex/Gender
ALL
Age
20 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Patients belonging to American Society of Anesthesiologists physical status I-II. * operation time less than 4 hours.

Exclusion criteria

* • American Society of Anesthesiology (ASA) physical status ≥ III. * Uncooperative or mentally retarded patients. * Known Allergy or hypersensitivity to lidocaine or bupivacaine. * Patients known to have gastritis or Gastro-oesophageal reflux disease (GERD). * History of PONV or motion sickness. * Operation duration (short less than 30 minutes or prolonged more than 240 min). * Patients with chronic renal disease (serum creatinine level ≥2.0mg/dl) or on renal replacement therapy (dialysis). * Patients with chronic cholecystitis (history of recurrent or persistent vomiting) * Skin inflammation and cellulitis.

Design outcomes

Primary

MeasureTime frameDescription
PONV incidence over 24hour postoperative24 hoursincidence of PONV according to PONV score from 0 to 3 where: 0= No nausea,no vomiting, 1= Nausea present, no vomiting, 2= Nausea present, vomiting present, 3= Vomiting\>2 episodes in 30 minutes, i.e., number of patients with PONV score of 0, number of patients with PONV score of 1, number of patients with PONV score of 2 and number of patients with PONV score of 3.

Secondary

MeasureTime frameDescription
Intraoperative and postoperative complications24 hoursComplications in the form of bleeding and facial nerve palsy
To monitor intraoperative hemodynamicsup to 4 hoursTo monitor intraoperative heart rate and blood pressure
post operative pain score measured by visual analogue score (VAS) from 0 to 10, where 0= no pain and 10= unbearable pain.up to 24 hours postoperativepost operative pain is assessed by visual analogue score from 0 to 10. patients are educated that 0= no pain, 5= distressing pain, 10= unbearable pain.
Need for postoperative analgesia24 hoursfirst analgesic request
To detect complications of regional ear block24 hoursrecord complications include (hematoma-facial nerve palsy-oedema)
Side effects and toxicity of drugs24 hoursrecord any side effects (local anaesthetic lidocaine-bupivacaine) e.g allergy, convulsions, hypotension.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026